SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-051230
Filing Date
2022-02-24
Accepted
2022-02-24 09:00:35
Documents
15
Period of Report
2022-02-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d318194d8k.htm   iXBRL 8-K 31233
2 EX-10.1 d318194dex101.htm EX-10.1 33360
3 EX-10.2 d318194dex102.htm EX-10.2 22482
  Complete submission text file 0001193125-22-051230.txt   280030

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA eftr-20220222.xsd EX-101.SCH 3583
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE eftr-20220222_def.xml EX-101.DEF 15890
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE eftr-20220222_lab.xml EX-101.LAB 25776
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eftr-20220222_pre.xml EX-101.PRE 16554
9 EXTRACTED XBRL INSTANCE DOCUMENT d318194d8k_htm.xml XML 7200
Mailing Address 142 NORTH CEDROS AVENUE, SUITE B SOLANA BEACH CA 92075
Business Address 142 NORTH CEDROS AVENUE, SUITE B SOLANA BEACH CA 92075 (858) 925-8215
eFFECTOR Therapeutics, Inc. (Filer) CIK: 0001828522 (see all company filings)

IRS No.: 853306396 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39866 | Film No.: 22666775
SIC: 2834 Pharmaceutical Preparations